Flomax
Product Images NDC 16590-489

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Flomax (NDC 16590-489). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Stat Rx Usa Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Flomax 0.4mg Label Image (Flomax 0.4mg Label)

The FLOMAX 0.4 mg capsule bottle label from STAT RX USA LLC shows packaging and distribution information, active ingredient Tamsulosin Hydrochloride 0.4 mg, package size of 30 capsules, and the NDC 16590-489-30. Manufacturer details include Boehringer Ingelheim Pharm., Ridgefield, CT, along with storage and dispensing information, plus a warning to keep out of reach of children.*

FDA Label Image

Figure 1 (Flomax Fig1)

A plasma concentration versus time graph comparing the pharmacokinetics of FLOMAX in fasted and fed states. The y-axis shows plasma concentration in ng/mL, and the x-axis shows time in hours up to 36 hours. The dashed line represents the fasted state with higher peak concentration, while the solid line represents the fed state with a lower peak concentration.*

FDA Label Image

Figure 2a (Flomax Fig2a)

A line graph showing the mean change over the duration of treatment in weeks for three groups: 0.8 mg treatment, 0.4 mg treatment, and placebo. The graph plots mean change on the vertical axis against weeks on the horizontal axis, demonstrating differences in treatment effect over time up to 13 weeks and the last observation carried forward (LOCF).*

FDA Label Image

Figure 2b (Flomax Fig2b)

This figure is a line graph showing the mean change over the duration of treatment in weeks, comparing three treatment groups: 0.8 mg dose, 0.4 mg dose, and placebo. The x-axis represents the treatment duration in weeks, and the y-axis shows the mean change. Different markers indicate each treatment group's progress across the study period.*

FDA Label Image

Figure 3a (Flomax Fig3a)

A line graph depicting the mean change over time in mL/sec for three groups: 0.8 mg treatment, 0.4 mg treatment, and placebo, across a duration of 13 weeks. Mean change values increase sharply within the first week for treatment groups and then stabilize, while placebo remains lower throughout the study period.*

FDA Label Image

Figure 3b (Flomax Fig3b)

A line graph depicting mean change in mL/sec over treatment duration in weeks for FLOMAX 0.8 mg, 0.4 mg, and placebo groups. The graph shows mean changes from baseline through various time points up to 13 weeks and last observation carried forward (LOCF), comparing different dosages and placebo effects.*

FDA Label Image

Flomax Structure (Flomax Struct)

Chemical structure diagram of the active ingredient in FLOMAX, showing molecular components including nitro, methoxy, and ether groups as well as a hydrochloride component, as presented in the image.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.